On Friday, Processa Pharmaceuticals Inc (NASDAQ: PCSA) was 10.36% up from the session before settling in for the closing price of $0.19. A 52-week range for PCSA has been $0.15 – $1.50.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 22.65%. When this article was written, the company’s average yearly earnings per share was at 88.37%. With a float of $43.77 million, this company’s outstanding shares have now reached $50.35 million.
Processa Pharmaceuticals Inc (PCSA) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Processa Pharmaceuticals Inc stocks. The insider ownership of Processa Pharmaceuticals Inc is 13.07%, while institutional ownership is 0.74%. The most recent insider transaction that took place on Jan 27 ’25, was worth 9,889. In this transaction Director of this company bought 12,400 shares at a rate of $0.80, taking the stock ownership to the 12,400 shares. Before that another transaction happened on Jan 27 ’25, when Company’s Chief Executive Officer bought 87,200 for $0.80, making the entire transaction worth $69,542. This insider now owns 87,200 shares in total.
Processa Pharmaceuticals Inc (PCSA) Latest Financial update
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted -1.03 earnings per share (EPS) during the time that was less than consensus figure (set at -1) by -0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.06 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 88.37% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 59.35% during the next five years compared to 22.65% growth over the previous five years of trading.
Processa Pharmaceuticals Inc (NASDAQ: PCSA) Trading Performance Indicators
You can see what Processa Pharmaceuticals Inc (PCSA) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 3.45.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.32, a number that is poised to hit -0.08 in the next quarter and is forecasted to reach -0.23 in one year’s time.
Technical Analysis of Processa Pharmaceuticals Inc (PCSA)
The latest stats from [Processa Pharmaceuticals Inc, PCSA] show that its last 5-days average volume of 4.23 million was inferior to 7.9 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 49.35%.
During the past 100 days, Processa Pharmaceuticals Inc’s (PCSA) raw stochastic average was set at 8.85%, which indicates a significant decrease from 75.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0163 in the past 14 days, which was lower than the 0.0353 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.2117, while its 200-day Moving Average is $0.4109. Now, the first resistance to watch is $0.2217. This is followed by the second major resistance level at $0.2303. The third major resistance level sits at $0.2457. If the price goes on to break the first support level at $0.1977, it is likely to go to the next support level at $0.1823. The third support level lies at $0.1737 if the price breaches the second support level.
Processa Pharmaceuticals Inc (NASDAQ: PCSA) Key Stats
There are 50,349K outstanding shares of the company, which has a market capitalization of 10.72 million. As of now, sales total 0 K while income totals -11,850 K. Its latest quarter income was 0 K while its last quarter net income were -3,930 K.
